NCT00143845 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Immunosuppression Taper | 42 / 54 | 30 / 54 | Not reported / Not reported |
Serious adverse events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 54
- term
- Diarrhea
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 54
- term
- GVHD
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- DVT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 54
- term
- Infection
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Primary Graft Failure
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 54
- term
- Fever
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Relapsed Disease
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 54
- term
- Hypotension
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 54
- term
- Vomiting
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Vertigo
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Headache
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Back Pain
Other reported adverse events
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 54
- term
- Hypomagnesemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 29
- num At Risk
- 54
- term
- Hyperglycemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 54
- term
- Hypoglycemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 54
- term
- Hypocalcemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 54
- term
- Hypercalcemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 54
- term
- Hypermagnesemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 54
- term
- Hyperkalemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 54
- term
- Hypokalemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 20
- num At Risk
- 54
- term
- Hyponatremia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 54
- term
- Hypernatremia
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 54
- term
- Creatinine
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 54
- term
- Esophogitis
Complete source fields
- event Groups
- description
- Reduced intensity conditioning consisting of Busulfan and Fludarabine(fludarabine 150 mg/m2 IV, busulfan 6 mg/kg IV, total lymphoid irradiation 2 Gy), followed by a rapid immunosuppressive taper of Tacrolimus (0.06 mg/kg q12h, PO, Days -7 to +28), Methotrexate (5 mg/m2, IV, Days +1, +3, +6, +11) and Mycophenolate Mofetil (10 mg/kg every 8 hours, PO, Days -6 to +7).
- id
- EG000
- other Num Affected
- 30
- other Num At Risk
- 54
- serious Num Affected
- 42
- serious Num At Risk
- 54
- title
- Immunosuppression Taper
- frequency Threshold
- 5
- other Events
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 54
- term
- Hypomagnesemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 29
- num At Risk
- 54
- term
- Hyperglycemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 54
- term
- Hypoglycemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 54
- term
- Hypocalcemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 54
- term
- Hypercalcemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 54
- term
- Hypermagnesemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 54
- term
- Hyperkalemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 54
- term
- Hypokalemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 20
- num At Risk
- 54
- term
- Hyponatremia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 54
- term
- Hypernatremia
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 54
- term
- Creatinine
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 54
- term
- Esophogitis
- serious Events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 54
- term
- Diarrhea
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 54
- term
- GVHD
- organ System
- Vascular disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- DVT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 54
- term
- Infection
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Primary Graft Failure
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 54
- term
- Fever
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Relapsed Disease
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 54
- term
- Hypotension
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 54
- term
- Vomiting
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Vertigo
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Headache
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 54
- term
- Back Pain
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle